FDA Issues Refusal-to-File Letter to Moderna for mRNA Influenza Vaccine
By
asplake
Toasted golden, schmeared with insight. Top of the rack.
Summary
The article criticizes the FDA's recent actions under the new administration, particularly focusing on a Refusal-to-File (RTF) letter issued to Moderna for their mRNA influenza vaccine mRNA-1010. The author expresses disappointment that the FDA has become more paternalistic with different preferences rather than embracing medical freedom, and suggests the agency has developed an "anti-vaccine fixation" especially against mRNA vaccines, which the author attributes to RFK Jr.'s influence. The piece presents this as a concerning development in regulatory oversight of medical innovations.
Key quotes
· 4 pulledI had high hopes and low expectations that the FDA under the new administration would be less paternalistic and more open to medical freedom.
Instead, what we are getting is paternalism with different preferences.
In particular, the FDA now appears to have a bizarre anti-vaccine fixation, particularly of the mRNA variety (disappointing but not surprising given the leadership of RFK Jr.).
The latest is that the FDA has issued a Refusal-to-File (RTF) letter to Moderna for their mRNA influenza vaccine, mRNA-1010.
You might also wanna read
Trump Appoints Don Jr.'s Hunting Partner Kyle Diamantas as Acting FDA Commissioner
The article discusses President Trump's appointment of Kyle Diamantas, a 38-year-old hunting companion of Donald Trump Jr., to serve as acti
Rolling Stone·18d ago
FDA Withdraws Proposed Regulation for Asbestos Testing in Cosmetic Talc, Reversing Public Health Progress
The article discusses the FDA's 2024 proposed regulation for testing asbestos in cosmetic talc, which would have been a significant public h
A Free-Market Perspective on Reducing Healthcare Costs
The article presents a free-market perspective on healthcare reform, arguing that healthcare costs are driven by expenses for personnel, dru
deanbaker22.substack.com·54m ago
NHS staff call for termination of Palantir data contract over privacy and privatisation concerns
An NHS staff member expresses deep concern over the Palantir contract, arguing that the private US tech company's access to patient data thr
the.organise.network·1h ago
Governo português retira afetação do imposto sobre bebidas açucaradas ao SNS, contrariando recomendação da OMS
O governo português decidiu que o imposto sobre bebidas açucaradas (conhecido como "imposto coca-cola") deixará de ser consignado ao Serviço
publico.pt·6h ago
6月1日診療報酬改定：初診料が実質190円増、予約キャンセル料の徴収も可能に
日本の厚生労働省は2026年6月1日に診療報酬を改定し、物価高と賃上げ対応のため初診時の料金が少なくとも190円上がる。初診料自体は2910円で据え置かれるが、物価上昇分20円とベースアップ評価料170円が上乗せされる。また、患者都合による診察直前の予約キャンセル料やWi-Fi利